← Leaderboards
Qing R Lu
Dana-Farber Cancer Institute
$11,955,147
Attributed
$12,564,577
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,564,577 · 11
By mechanism
R01$10,879,824 · 6
R37$1,589,895 · 1
P41$57,342 · 3
F32$37,516 · 1
Top collaborators
- Mei Xin2 shared
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticMolecularIn VivoMediatingBaseGenome-WideOligodendrogliaSignal TransductionMyelinationMultiple SclerosisSignal PathwayOligodendrocyte LineageDemyelinating DiseasesMyelinInjuryGenesNeuraxisPlayInsightAnimalsComplexGene TargetingAblationTranscription Factor
Grant awards (40)
Molecular Mechanisms of Oligodendrocyte Myelination and remyelination$614,009
R01 · FY2025 · NS · contact PI
Glial Origin and Signaling in Medulloblastoma$604,852
R01 · FY2025 · NS · contact PI
Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis$529,965
R37 · FY2018 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$466,702
R01 · FY2018 · NS · contact PI
Chromatin remodeling control of myelination and remyelination$446,256
R01 · FY2018 · NS · contact PI
Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis$529,965
R37 · FY2017 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$466,702
R01 · FY2017 · NS · contact PI
Chromatin remodeling control of myelination and remyelination$446,256
R01 · FY2017 · NS · contact PI
Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis$529,965
R37 · FY2016 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$466,702
R01 · FY2016 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$341,250
R01 · FY2016 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$341,250
R01 · FY2016 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$466,702
R01 · FY2015 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$341,250
R01 · FY2015 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$341,250
R01 · FY2015 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$337,838
R01 · FY2014 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$337,837
R01 · FY2014 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$331,080
R01 · FY2014 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$216,239
R01 · FY2013 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$206,700
R01 · FY2013 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$206,700
R01 · FY2013 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$128,939
R01 · FY2013 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$128,939
R01 · FY2013 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$112,686
R01 · FY2013 · NS · contact PI
Chromatin Remodeling Control of CNS Myelination and Remyelination$347,356
R01 · FY2012 · NS · contact PI
A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets$347,356
R01 · FY2012 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$340,856
R01 · FY2012 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$339,784
R01 · FY2011 · NS · contact PI
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination$346,719
R01 · FY2010 · NS · contact PI
USING THE OPTIMAL RECEIVER OPERATING CHARACTERISITC CURVE$19,768
P41 · FY2010 · RR · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$342,057
R01 · FY2009 · NS · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$50,836
R01 · FY2009 · NS · contact PI
USING THE OPTIMAL RECEIVER OPERATING CHARACTERISITC CURVE$19,393
P41 · FY2009 · RR · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$17,584
R01 · FY2009 · NS · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$342,057
R01 · FY2008 · NS · contact PI
USING THE OPTIMAL RECEIVER OPERATING CHARACTERISITC CURVE$18,181
P41 · FY2008 · RR · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$342,057
R01 · FY2007 · NS · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$352,273
R01 · FY2006 · NS · contact PI
Olig2 in Oligodendrocyte Myelination and Remyelination$360,750
R01 · FY2005 · NS
MOLECULAR MECHANISM OF RETROGRADE SIGNALING IN AXONS$37,516
F32 · FY2000 · NS